DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Edluar (Zolpidem Tartrate) - Published Studies

 
 



Edluar Related Published Studies

Well-designed clinical trials related to Edluar (Zolpidem)

Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial. [2013]

Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study. [2013]

Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. [2011.07]

The use of a non-benzodiazepine hypnotic sleep-aid (Zolpidem) in patients undergoing ACL reconstruction: a randomized controlled clinical trial. [2011.05]

Zolpidem and zopiclone impair similarly monotonous driving performance after a single nighttime intake in aged subjects. [2011.04]

Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study. [2011.02.01]

A double-blind, randomized, comparative study to evaluate the efficacy and safety of zaleplon versus zolpidem in shortening sleep latency in primary insomnia. [2011.01]

Influence of zolpidem and sleep inertia on balance and cognition during nighttime awakening: a randomized placebo-controlled trial. [2011.01]

Comparing effects of clonazepam and zolpidem on sleep quality of patients on maintenance hemodialysis. [2011]

A double-blind, randomized, comparative study to evaluate the efficacy and safety of zaleplon versus zolpidem in shortening sleep latency in primary insomnia. [2011]

Alterations in cyclic alternating pattern associated with phase advanced sleep are differentially modulated by gaboxadol and zolpidem. [2010.11]

Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep. [2010.11]

Zolpidem for persistent vegetative state--a placebo-controlled trial in pediatrics. [2010.10]

Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial. [2010.09]

Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia. [2010.06]

Modafinil and zolpidem use by emergency medicine residents. [2009.12]

Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers. [2009.07]

Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder. [2009.06]

Short-term clarithromycin administration impairs clearance and enhances pharmacodynamic effects of trazodone but not of zolpidem. [2009.06]

Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study. [2009.06]

Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial. [2009.05]

Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age. [2009.05]

A therapeutic dose of zolpidem reduces thalamic GABA in healthy volunteers: a proton MRS study at 4 T. [2009.05]

Improvement of idiopathic central sleep apnea with zolpidem. [2009.04.15]

Tolerability, pharmacokinetics and night-time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects. [2009.02]

Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers. [2008.12]

Zolpidem extended-release 12.5 mg associated with improvements in work performance in a 6-month randomized, placebo-controlled trial. [2008.10.01]

Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings. [2008.09.01]

Use of computerized dynamic posturography to assess balance in older adults after nighttime awakenings using zolpidem as a reference. [2008.07.15]

Hypnotherapy in the treatment of chronic combat-related PTSD patients suffering from insomnia: a randomized, zolpidem-controlled clinical trial. [2008.07]

A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia. [2008.06.15]

Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo. [2008.05]

Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. [2008.01.01]

A randomized, controlled prospective trial of zolpidem and haloperidol for use as sleeping agents in pediatric burn patients. [2008.01]

Efficacy and Safety of Zolpidem Extended Release in Elderly Primary Insomnia Patients. [2008.01]

Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate. [2008.01]

Evaluation of automated and semi-automated scoring of polysomnographic recordings from a clinical trial using zolpidem in the treatment of insomnia. [2007.11.01]

Zaleplon and zolpidem objectively alleviate sleep disturbances in mountaineers at a 3,613 meter altitude. [2007.11.01]

Acute effects of zolpidem on daytime alertness, psychomotor and physical performance. [2007.11]

Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine. [2007.07]

Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy. [2007.07]

[Effects of paroxetine with or without zolpidem on depression with insomnia: a multi-center randomized comparative study] [2007.06.19]

Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjects. [2007.01]

Well-designed clinical trials possibly related to Edluar (Zolpidem)

Tolerability, pharmacokinetics, and pharmacodynamics of single-dose almorexant, an orexin receptor antagonist, in healthy elderly subjects. [2013]

Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition. [2011.07]

Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor agonist, in recreational polydrug users. [2011.05]

A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome. [2011.01]

MSLT in primary insomnia: stability and relation to nocturnal sleep. [2011]

Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor agonist, in recreational polydrug users. [2011]

A safety trial of sodium oxybate in patients with obstructive sleep apnea: Acute effects on sleep-disordered breathing. [2010.01]

Effect of hypnotic drugs on body balance and standing steadiness. [2010]

Validation of the sleep impact scale in patients with major depressive disorder and insomnia. [2009.07]

Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. [2009.05.20]

An evaluation of the neuroendocrine response to sleep in pediatric burn patients. [2009.05]

Differing effects of intracortical circuits on plasticity. [2009.03]

A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety. [2009.03]

Effect of ramelteon on middle-of-the-night balance in older adults with chronic insomnia. [2009.02.15]

Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers. [2008.03]

Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy? [2008]

Short-term treatment with gaboxadol improves sleep maintenance and enhances slow wave sleep in adult patients with primary insomnia. [2007.11]

Segregating two inhibitory circuits in human motor cortex at the level of GABAA receptor subtypes: A TMS study. [2007.10]

The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia. [2007.05.01]

A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers. [2007.05]

Other research related to Edluar (Zolpidem)

Comparison of pharmacokinetic profiles of zolpidem buffered sublingual tablet and zolpidem oral immediate-release tablet: results from a single-center, single-dose, randomized, open-label crossover study in healthy adults. [2013]

Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia. [2012]

The effect of zolpidem on sleep quality, stress status, and nondipping hypertension. [2012]

EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem in patients with primary insomnia. [2012]

Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study. [2012]

EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem in patients with primary insomnia. [2011.11.05]

Comparing effects of clonazepam and zolpidem on sleep quality of patients on maintenance hemodialysis. [2011.11]

Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study. [2011.10.16]

Zolpidem dependence and withdrawal seizure--report of two cases. [2011.03]

Pregabalin in zolpidem dependence and withdrawal. [2011.03]

Effects of Alprazolam, Zolpidem and Zopiclone, and of chronic inflammation on peripheral experimental algesia in Wistar rats. [2011]

Zolpidem reduces the blood oxygen level-dependent signal during visual system stimulation. [2011]

The use of a non-benzodiazepine hypnotic sleep-aid (Zolpidem) in patients undergoing ACL reconstruction: a randomized controlled clinical trial. [2011]

Influence of zolpidem and sleep inertia on balance and cognition during nighttime awakening: a randomized placebo-controlled trial. [2011]

Increased risk of adverse pregnancy outcomes in women receiving zolpidem during pregnancy. [2010.09]

Zolpidem poisoning in a cat. [2010.08]

[Single and combining effects of Calculus Bovis and zolpidem on inhibitive neurotransmitter of rat striatum corpora] [2010.04]

Clinical and brain SPECT scan response to zolpidem in patients after brain damage. [2010]

Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia. [2010]

Zolpidem for persistent vegetative state--a placebo-controlled trial in pediatrics. [2010]

Alterations in cyclic alternating pattern associated with phase advanced sleep are differentially modulated by gaboxadol and zolpidem. [2010]

Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial. [2010]

Mapping a barbiturate withdrawal locus to a 0.44 Mb interval and analysis of a novel null mutant identify a role for Kcnj9 (GIRK3) in withdrawal from pentobarbital, zolpidem, and ethanol. [2009.09.16]

Effect of zolpidem on the sleep arousal response to nocturnal esophageal acid exposure. [2009.09]

A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients. [2009.08]

Pharmacokinetics, pharmacodynamics and the pharmacokinetic/pharmacodynamic relationship of zolpidem in healthy subjects. [2009.07.31]

Paradoxical effects of the hypnotic Zolpidem in the neonatal ferret. [2009.07.19]

Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep. [2009.06.01]

Zolpidem in fatigue management for surge operations of remotely piloted aircraft. [2009.06]

Effects of acute and repeated zolpidem treatment on pentylenetetrazole-induced seizure threshold and on locomotor activity: comparison with diazepam. [2009.06]

Novel zolpidem formulations. [2009.05]

Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers. [2009.05]

Other possibly related research studies

Catatonia recognition and treatment. [2009.08]

A fatal case of benzodiazepine withdrawal. [2009.06]

Sleepwalking in psychiatric patients: comparison of childhood and adult onset. [2009.05]

5-HT1A receptor blockade reverses GABA(A) receptor alpha3 subunit-mediated anxiolytic effects on stress-induced hyperthermia. [2010.08]

Medication Use and Functional Status Decline in Older Adults: A Narrative Review. [2011.11.04]

Predicting which medication classes interfere with allergy skin testing. [2010.11]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014